Agilent Technologies Inc.

Reputation and brand · Brand damage and negative publicity

If we or any of our suppliers, distributors or customers fail to comply with Food and Drug Administration regulations and other applicable regulatory requirements or are perceived to potentially have failed to comply, we may face adverse publicity affecting both us and our customers.

Project and contract management · Government contract dependency

We derive a portion of our revenue from direct and indirect sales to U.S. federal, state, local, and foreign governments and their respective agencies. Failure to comply with these laws, regulations or provisions in our government contracts could result in the imposition of various civil and criminal penalties, suspension of government contracts or debarment.

Human capital and workforce · Talent acquisition and retention

Our business will suffer if we are not able to retain and hire key personnel. Our future success depends partly on the continued service of our key research, engineering, sales, marketing, manufacturing, executive and administrative personnel. There is intense competition for certain highly technical specialties in geographic areas where we continue to recruit.

Geopolitical and trade · International conflicts and tensions

Actual or anticipated military or political conflicts, including uncertainties and instability in economic and market conditions caused by conflicts in Ukraine/Russia and the Middle East, and political and trade uncertainties in the greater China region.

Economic and market conditions · Inflation and deflation pressures

Slower global economic growth, increasing interest rates, inflationary pressures, instability and uncertainty in the markets in which we operate may adversely impact our business. In addition, a significant amount of certain types of expenses, such as payroll, utilities, tax, and marketing expenses, are paid in local currencies.

Social and demographic · Public perception and reputation

Our reputation, ability to do business and financial statements may be harmed by improper conduct by any of our employees, agents or business partners. Any such improper actions or allegations of such acts could damage our reputation and subject us to civil or criminal investigations.

Natural and catastrophic events · Terrorism and security threats

Our factories, facilities and distribution system are subject to the risk of catastrophic loss due to fire, flood, terrorism, public health crises, increasing severity or frequency of extreme weather events. We do not carry insurance or financial reserves for interruptions or potential losses arising from earthquakes or terrorism.

Natural and catastrophic events · Climate change and environmental impact

In the event that any future climate change legislation would require that stricter standards be imposed by domestic or international environmental regulatory authorities, we may be required to make certain changes and adaptations to our manufacturing processes and facilities. We cannot predict how changes will affect our business operations or the cost of compliance.

Natural and catastrophic events · Pandemic and public health crises

Our global operations expose us to risks associated with public health crises, including epidemics and pandemics. Public health crises, and any related remediation measures such as quarantine, curfew and other travel and activity restrictions, may impact our operations and sales and delivery of products and services.

Industry regulation · Fda drug and device approval

We are subject to extensive regulation by the Food and Drug Administration and certain similar foreign regulatory agencies. A number of our products and services are subject to regulation by the Food and Drug Administration. These regulations govern a wide variety of product and service-related activities, from quality management, design and development to manufacturing, labeling, promotion, sales, distribution and post-market surveillance.

Legal and litigation · Intellectual property disputes

Third parties may claim that we are infringing their intellectual property, and we could suffer significant litigation or licensing expenses or be prevented from selling products or services. A claim of intellectual property infringement could force us to enter into a costly or restrictive license agreement or could require us to redesign our products.

Legal and litigation · Product liability and warranty claims

If we or any of our suppliers, distributors or customers fail to comply with Food and Drug Administration regulations and other applicable regulatory requirements, we may face seizures or recalls of our products or those of our customers; corresponding customer and third party claims.

Industry regulation · Regulatory compliance and changes

Our customers and we are subject to various significant international, federal, state and local regulations, including but not limited to regulations in the areas of health and safety, packaging, product content, employment, labor and immigration, import/export controls, trade restrictions and anti-competition.

Tax and financial reporting · Audit and regulatory examinations

We are also subject to examinations of our tax returns by tax authorities in various jurisdictions around the world. We regularly assess the likelihood of adverse outcomes resulting from ongoing tax examinations to determine the adequacy of our provision for taxes.

Legal and litigation · Litigation and legal proceedings

From time to time, third parties may claim that one or more of our products or services infringe their intellectual property rights. Any dispute or litigation regarding patents or other intellectual property could be costly and time-consuming due to the complexity of our technology and the uncertainty of intellectual property litigation.

Cybersecurity and data protection · Data privacy and protection regulations

As a global organization, we are subject to data privacy and security laws, regulations, and customer-imposed controls in numerous jurisdictions as a result of having access to and processing confidential, personal, sensitive and/or patient health data. Global privacy laws, including the EU's General Data Protection Regulation, China's Personal Information Protection Law and Data Security Law, the California Consumer Privacy Act and Brazil's Lei Geral de Protecao de Dados, apply to our activities.

Technology infrastructure · Technology systems and infrastructure failure

We rely on several centralized information technology systems throughout our company to provide products and services, keep financial records, process orders, manage inventory, process shipments to customers and operate other critical functions. Our information technology systems may be susceptible to damage, disruptions or shutdowns due to power outages, hardware failures, computer viruses, attacks by computer hackers.

Cybersecurity and data protection · Third party data security and vendors

Our currency hedging programs involve third-party financial institutions as counterparties. The weakening or failure of financial institution counterparties may adversely affect our hedging programs and our financial condition.

Market and investment · Asset valuation and impairment

In the future, we may be required to record charges to earnings during the period if we determine there is an impairment of goodwill or intangible assets, up to the full amount of the value of the assets, or, in the case of strategic investments and alliances, consolidate results, including losses, of third parties.

Market and investment · Interest rate and yield curve risk

Our retirement and post retirement pension plan assets and obligations are subject to financial market risks. The performance of the financial markets and interest rates impact our plan expenses and funding obligations. Significant decreases in market interest rates will increase our funding obligations.